Drug Shortage Report for DEXAMETHASONE-OMEGA
Report ID | 129153 |
Drug Identification Number | 02204266 |
Brand name | DEXAMETHASONE-OMEGA |
Common or Proper name | Dexamethasone Sodium Phosphate Injection USP |
Company Name | OMEGA LABORATORIES LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | DEXAMETHASONE PHOSPHATE |
Strength(s) | 4MG |
Dosage form(s) | LIQUID |
Route of administration | INTRA-ARTICULAR INTRALESIONAL INTRAMUSCULAR INTRAVENOUS SOFT TISSUE INJECTION INTRA-ARTICULAR INTRALESIONAL INTRAMUSCULAR INTRAVENOUS SOFT TISSUE INJECTION |
Packaging size | 5 x 5mL vial / fiole |
ATC code | H02AB |
ATC description | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2020-06-18 |
Estimated end date | Unknown |
Actual end date | 2021-03-01 |
Shortage status | Resolved |
Updated date | 2021-03-24 |
Company comments | On allocation for Covid. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-03-24 | French | Compare |
v3 | 2021-03-24 | English | Compare |
v2 | 2020-11-30 | French | Compare |
v1 | 2020-11-30 | English | Compare |
Showing 1 to 4 of 4